Moutaz F. Derbala

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease.

The African Middle East Association of Gastroenterology (AMAGE) clinical practice guidelines for the diagnosis and management of metabolic dysfunction associated fatty liver disease.

Journal: Annals of hepatology

Published: October 01, 2025

Nanoparticle approaches for hepatitis therapy and clinical translation.

Nanoparticle approaches for hepatitis therapy and clinical translation.

Journal: Discover nano

Published: September 24, 2025

The Current and Future Burden of Metabolic Dysfunction-related Cancers in Arab Countries, 2022-2050.

The Current and Future Burden of Metabolic Dysfunction-related Cancers in Arab Countries, 2022-2050.

Journal: Oman medical journal

Published: August 08, 2025

The burden of metabolic diseases in the Arab region, 1990-2021.

The burden of metabolic diseases in the Arab region, 1990-2021.

Journal: Therapeutic advances in endocrinology and metabolism

Published: July 28, 2025

Metabolic associated steatotic liver disease in Qatar: Analysis of dietary patterns and nutrient intake.

Metabolic associated steatotic liver disease in Qatar: Analysis of dietary patterns and nutrient intake.

Journal: World journal of hepatology

Published: July 16, 2025

Changing profile and burden of hepatocellular carcinoma in Arab Countries in 1990-2021.

Changing profile and burden of hepatocellular carcinoma in Arab Countries in 1990-2021.

Journal: Annals of hepatology

Published: June 03, 2025

Risk of Malignancy in Indeterminate Liver Nodules Among Patients with Cirrhosis: A Retrospective Cohort Study.

Risk of Malignancy in Indeterminate Liver Nodules Among Patients with Cirrhosis: A Retrospective Cohort Study.

Journal: Journal of gastrointestinal cancer

Published: September 29, 2024

Global multi-societies endorsement of the MAFLD definition.

Global multi-societies endorsement of the MAFLD definition.

Journal: Annals of hepatology

Published: August 07, 2024

MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease.

MAFLD criteria are better than MASLD criteria at predicting the risk of chronic kidney disease.

Journal: Annals of hepatology

Published: April 17, 2024

Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition.

Joint position statement from the Middle East and North Africa and sub-Saharan Africa on continuing to endorse the MAFLD definition.

Journal: Journal of hepatology

Published: January 25, 2024

Seroprevalence and clinical outcome of hepatitis D infection in Qatar.

Seroprevalence and clinical outcome of hepatitis D infection in Qatar.

Journal: Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit

Published: November 15, 2021

Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C.

Development and multicenter validation of FIB-6: A novel, machine learning, simple bedside score to rule out liver cirrhosis and compensated advanced chronic liver disease in patients with chronic hepatitis C.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: September 20, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026